Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             58 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adherence and discontinuation rates in patients on Tecfidera™ (dimethyl fumarate): Long-term Canadian experience from the Biogen ONE™ support program Thompson, Mattea Tan

67 C p.
artikel
2 Archetypal analysis of visual fields in optic neuritis reveals functional biomarkers associated with outcome and treatment response Solli, Elena

67 C p.
artikel
3 Assessment of T2 lesion-based disease activity volume outcomes in predicting disease progression in multiple sclerosis over 10 years Oship, Devon

67 C p.
artikel
4 Association between disease-modifying therapies and adverse clinical outcomes in multiple sclerosis patients with COVID-19 infection Maghbooli, Zhila

67 C p.
artikel
5 Association of age and disease duration with comorbidities and disability: A study of the Swiss Multiple Sclerosis Registry Stanikić, Mina

67 C p.
artikel
6 Clinical onset of CNS demyelinating disease after COVID-19 vaccination: denovo disease? Gernert, J.A.

67 C p.
artikel
7 Cognitive-motor interference in people with mild to moderate multiple sclerosis, in comparison with healthy controls Wallin, Andreas

67 C p.
artikel
8 Combined progressive functional exercise effect on contactin-1 and contactin-2 level in mildly disabled persons with multiple sclerosis Bilek, Furkan

67 C p.
artikel
9 Common variable immunodeficiency and its inflammatory neurological manifestations: A case report and literature review Martins, Bárbara

67 C p.
artikel
10 Corrigendum to ‘ Incidence and risk factors for venous thromboembolism during an acute attack in patients with neuromyelitis optica spectrum disorders’ [Multiple Sclerosis and Related Disorders 58(2022) 103513] Pan, Juyuan

67 C p.
artikel
11 Depressive symptoms, fatigue and the level of physical activity during perimenopause in women with multiple sclerosis Machado, Eduarda Faria Abrahao

67 C p.
artikel
12 Does the use of the Bruton Tyrosine Kinase inhibitors and the c-kit inhibitor masitinib result in clinically significant outcomes among patients with various forms of multiple sclerosis? Arsenault, Shane

67 C p.
artikel
13 EBV and multiple sclerosis: Setting the research agenda Giovannoni, Gavin

67 C p.
artikel
14 Economic evaluation of cladribine tablets in high disease activity (HDA) relapsing multiple sclerosis (RMS) patients in Lebanon Matni, Mirna

67 C p.
artikel
15 Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein-Barr virus in multiple sclerosis. A pilot study Zivadinov, Robert

67 C p.
artikel
16 Effects of Acceptance and Commitment Therapy (ACT) and Mindfulness-Based Stress Reduction (MBSR) on symptoms and emotional competencies in individuals with multiple sclerosis Sadeghi-Bahmani, Dena

67 C p.
artikel
17 Efficacy, safety and tolerability of dimethylfumarate during pregnancy and breastfeeding Borriello, Giovanna

67 C p.
artikel
18 Facial involvement in multiple sclerosis Etemadifar, Masoud

67 C p.
artikel
19 Fingolimod, teriflunomide and cladribine for the treatment of multiple sclerosis in women of childbearing age: description of drug utilization and exposed pregnancies in Germany Platzbecker, Katharina

67 C p.
artikel
20 Gains in multiple sclerosis knowledge following completion of the Understanding Multiple Sclerosis online course are maintained six months after course completion Claflin, Suzi B

67 C p.
artikel
21 Gut microbiome in multiple sclerosis-related cognitive impairment Ghadiri, Fereshteh

67 C p.
artikel
22 Heat and cold sensitivity in multiple sclerosis: A patient-centred perspective on triggers, symptoms, and thermal resilience practices Christogianni, Aikaterini

67 C p.
artikel
23 High-efficacy therapy reduces subcortical grey matter volume loss in Japanese patients with relapse-onset multiple sclerosis: A 2-year cohort study Yokote, Hiroaki

67 C p.
artikel
24 Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes Holroyd, Kathryn B.

67 C p.
artikel
25 Identification of disability status in persons with multiple sclerosis by lower limb neuromuscular function – Emphasis on rate of force development Taul-Madsen, Laurits

67 C p.
artikel
26 Illness perceptions and outcome in multiple sclerosis: A systematic review of the literature Luca, Maria

67 C p.
artikel
27 Impact of Covid-19 emergency on rehabilitation services for Multiple Sclerosis: An international RIMS survey Brichetto, Giampaolo

67 C p.
artikel
28 Improvement in the multiple sclerosis functional composite score by multi-function swing suspension training program Sepehri Far, Sara

67 C p.
artikel
29 Inflammatory markers of hemogram parameters as predictive factors for disease severity in anti-N-methyl-D-aspartate receptor encephalitis Zhang, Yin-Xi

67 C p.
artikel
30 Interpreting the clinical importance of the relationship between subjective fatigue and cognitive impairment in multiple sclerosis (MS): How BICAMS performance is affected by MS-related fatigue Bellew, David

67 C p.
artikel
31 Investigation of serum adropin levels and its relationship with hypothalamic atrophy in patients with multiple sclerosis Demirdöğen, Filiz

67 C p.
artikel
32 Menopausal symptoms and hormone therapy in women with multiple sclerosis: A baseline-controlled study Juutinen, Laura

67 C p.
artikel
33 Monkeypox in Multiple Sclerosis patients: Should we be alert? Boldrini, Vinícius Oliveira

67 C p.
artikel
34 MR imaging in children with transverse myelitis and acquired demyelinating syndromes El Naggar, Ines

67 C p.
artikel
35 Pattern of thalamic nuclei atrophy in early relapse-onset multiple sclerosis Levy, Sarah

67 C p.
artikel
36 Peripheral nerve vulnerability as risk factor for multiple sclerosis: Possible insights from Neurofibromatosis type 2 (NF2) Schulz, Alexander

67 C p.
artikel
37 Possible evidence of near transfer effects after adaptive working memory training in persons with multiple sclerosis Esbrí, Sónia Félix

67 C p.
artikel
38 Prolonged visual evoked potential latency predicts longitudinal worsening of fatigue in people with multiple sclerosis Covey, Thomas J.

67 C p.
artikel
39 Protective effects of Herbal Compound (IM253) on the inflammatory responses and oxidative stress in a mouse model of multiple sclerosis Esmaeilzadeh, Emran

67 C p.
artikel
40 Psychological flexibility, distress, and quality of life in secondary progressive multiple sclerosis: A cross-sectional study Meek, Christopher

67 C p.
artikel
41 Reasons for non-completion of a massive open online course about multiple sclerosis: A mixed methods study Claflin, Suzi

67 C p.
artikel
42 Relationship of coping strategies with mood symptoms, disease related characteristics and demographic variables in patients with multiple sclerosis: A systematic review study Bahmani, Bahman

67 C p.
artikel
43 Revisiting the antiviral theory to explain interferon-beta's effectiveness for relapsing multiple sclerosis Sedaghat, Nahad

67 C p.
artikel
44 Risk factors for development of lymphopenia in dimethyl fumarate-treated patients with multiple sclerosis Ravn, Julie

67 C p.
artikel
45 Serum glial fibrillary acidic protein correlates with retinal structural damage in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder Lin, Ting-Yi

67 C p.
artikel
46 Serum neurofilament levels in patients with multiple sclerosis: A comparison of SIMOA and high sensitivity ELISA assays and contributing factors to ELISA levels Revendova, K. Zondra

67 C p.
artikel
47 sNFL applicability as additional monitoring tool in natalizumab extended interval dosing regimen for RRMS patients Valentino, Paola

67 C p.
artikel
48 Stages of brain volume loss and performance in the Brief International Cognitive Assessment for Multiple Sclerosis Miyazaki, Yusei

67 C p.
artikel
49 Symptom improvements following therapeutic use of cannabis-based products in French people with multiple sclerosis Barré, Tangui

67 C p.
artikel
50 The biological rabbit hole: Only for the blind Hawkes, Christopher H

67 C p.
artikel
51 The figure-of-eight walk test is a reliable and valid test for assessing walking skill in people with multiple sclerosis Soke, Fatih

67 C p.
artikel
52 The impact of sociodemographic characteristics on diagnosis and access to disease-modifying treatment for patients with multiple sclerosis in Morocco Lotfi, Rachid

67 C p.
artikel
53 The Prevalence, Demographics, Clinical Features, Neuroimaging, and Inter-ethnic Differences of MOGAD in Malaysia with Global Perspectives Ong, ZM

67 C p.
artikel
54 The relationship between stress and disease onset and relapse in multiple sclerosis: A systematic review Jiang, Jessie

67 C p.
artikel
55 Transcranial direct current stimulation for spasticity in patients with multiple sclerosis: Exploring novel routes El Habashy, Hala Rashad

67 C p.
artikel
56 Unmet need for family planning and fertility preferences in women with multiple sclerosis López-Reyes, Lorena

67 C p.
artikel
57 Vaccination of multiple sclerosis patients during the COVID-19 era: Novel insights into vaccine safety and immunogenicity Kim, Enoch

67 C p.
artikel
58 Validation of a brief cross-cultural cognitive screening test in Multiple Sclerosis Delgado-Álvarez, Alfonso

67 C p.
artikel
                             58 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland